1-Piperonylpiperazine

1-Piperonylpiperazine (MDBP) is metabolized by demethylenation and subsequent methylation to N- (4-hydroxy-3-methoxybenzyl) piperazine followedby partial glucuronidation or sulfation. 1-Piperonylpiperazine can alter the disposition and metabolism of 3,4-methylenedioxymethamphetamine (MDMA) in the brain and in peripheral organs. 1-Piperonylpiperazine can inhibit the MDMA-induced neurotoxicity[1].

Product Specifications

CAS Number

[32231-06-4]

Product Name Alternative

MDBP

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Neurological Disease

Purity

99.56

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

C1(CN2CCNCC2)=CC3=C(OCO3)C=C1

Molecular Formula

C12H16N2O2

Molecular Weight

220.27

Precautions

H315, H319, H335

References & Citations

[1]Staack, R. F., & Maurer, H. H. (2004) . New designer drug 1- (3,4-methylenedioxybenzyl) piperazine (MDBP) : studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. Journal of mass spectrometry : JMS, 39 (3), 255–261.